Anika Therapeutics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Insmed INSM:US USD 807.48M 366K
Integra Lifesciences IART:US USD 1.49B 10.9M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Merit Medical Systems MMSI:US USD 205.41M 30.29M
Peregrine Pharmaceuticals PPHM:US USD 141.93M 128K
Smith & Nephew PLC SN/:LN 2.28B 567M
Stryker SYK:US USD 11.86B 894M
Veracyte VCYT:US USD 500K 100K
Zimmer Biomet Holdings Inc ZBH:US USD 5.15B 97M